نتائج البحث

Profiling of Tumour-Infiltrating Lymphocytes and Tumour-Associated Macrophages in Ovarian Epithelial Cancer—Relation to Tumour Characteristics and Impact on Prognosis.

• Authors : Stout, Annabel¹ (AUTHOR) ; Facey, Natalya² (AUTHOR) ; Bhatnagar, Anjali³ (AUTHOR)

Subjects: *OVARIAN epithelial cancer; *TUMOR-infiltrating immune cells; *PROGNOSIS

• Source: International Journal of Molecular Sciences. Apr2024, Vol. 25 Issue 8, p4524. 14p.

تفاصيل العنوان

Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

• Authors : NRG Oncology

• Source: GOG-0262: A Phase III Trial of Every-3-Weeks Paclitaxel Versus Dose Dense Weekly Paclitaxel in Combination With Carboplatin With or Without Concurrent and Consolidation Bevacizumab (NSC #704865) in

تفاصيل العنوان

Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer

• Authors : National Cancer Institute (NCI)

• Source: Phase I Trial of Intraperitoneal Administration of a) a CEA-Expressing Derivative, and b) a NIS-Expressing Derivative Manufactured From a Genetically Engineered Strain of Measles Virus in Patients

تفاصيل العنوان

Pazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

• Source: Phase IB-II, Open Label, Multicenter Feasibility Study of Pazopanib in Combination With Paclitaxel and Carboplatin in Patients With Platinum-Refractory/Resistant

تفاصيل العنوان

Decitabine, Vaccine Therapy, and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

• Authors : Eisai Inc.

• Source: A Phase I Clinical Trial of NY-ESO-1 Protein Immunization in Combination With 5-AZA-2'-Deoxycytidine (Decitabine) in Patients Receiving Liposomal Doxorubicin for Recurrent

تفاصيل العنوان

Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Ovarian Epithelial Cancer

• Authors : National Cancer Institute (NCI)

• Source: Single-Dose, Cohort Study of Increasing Doses of Yttrium-90 Conjugated to Humanized Monoclonal Antibody 3S193 (90Y-hu3S193) in Patients With Advanced Ovarian

تفاصيل العنوان

Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer (Fludarabine Treatment Closed as of 12/01/2009)

• Authors : National Cancer Institute (NCI)

• Source: A Phase I Dose Escalation Safety and Feasibility Study of WT1-Specific T Cells for the Treatment of Patients With Advanced Ovarian, Primary Peritoneal, and Fallopian

تفاصيل العنوان

The Progression and Prospects of the Gene Expression Profiling in Ovarian Epithelial Cancer

• Authors : Banushree Chandrasekhar Srinivasamurthy; Subhashini Ramamoorthi

Subjects: chemoresistance; gene signature; high-grade serous carcinoma

• Source: Gynecology and Minimally Invasive Therapy, Vol 13, Iss 3, Pp 141-145 (2024)

تفاصيل العنوان

Adipocyte derived exosomes promote cell invasion and challenge paclitaxel efficacy in ovarian cancer.

• Authors : Williams, Michael Ellis¹ (AUTHOR); Howard, David¹ (AUTHOR); Donnelly, Claire¹ (AUTHOR)

• Source: Cell Communication & Signaling. 9/16/2024, Vol. 22 Issue 1, p1-18. 18p.

تفاصيل العنوان

Human papillomavirus infection of the fallopian tube as a potential risk factor for epithelial ovarian cancer.

• Authors : Paradowska, Edyta¹ (AUTHOR) ; Haręża, Daria A.^1,2 (AUTHOR); Kania, Katarzyna D.¹ (AUTHOR)

• Source: Scientific Reports. 9/16/2024, Vol. 14 Issue 1, p1-12. 12p.

تفاصيل العنوان